메뉴 건너뛰기




Volumn 39, Issue 3, 2010, Pages 269-276

Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancer

Author keywords

Chemoradiotherapy; Epidermal growth factor receptor; Serum vascular endothelial growth factor; Targeted therapies

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; VASCULOTROPIN;

EID: 77953504513     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2009.090095     Document Type: Article
Times cited : (9)

References (23)
  • 1
    • 0041497693 scopus 로고    scopus 로고
    • Differential expression of epidermal growth factor receptor in human head and neck cancers
    • Ke LD, Adler-Storthz K, Clayman GL, et al. Differential expression of epidermal growth factor receptor in human head and neck cancers. Head Neck 1998;20:320-7.
    • (1998) Head Neck , vol.20 , pp. 320-327
    • Ke, L.D.1    Adler-Storthz, K.2    Clayman, G.L.3
  • 2
    • 0032478998 scopus 로고    scopus 로고
    • Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival
    • Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 824-832
    • Rubin Grandis, J.1    Melhem, M.F.2    Gooding, W.E.3
  • 3
    • 0029831041 scopus 로고    scopus 로고
    • Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
    • Rubin Grandis J, Melhem MF, Barnes EL, et al. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996;78:1284-92.
    • (1996) Cancer , vol.78 , pp. 1284-1292
    • Rubin Grandis, J.1    Melhem, M.F.2    Barnes, E.L.3
  • 4
    • 0037115674 scopus 로고    scopus 로고
    • Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma
    • Ang KK, Berkey BA, Tu X, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-6. (Pubitemid 36025259)
    • (2002) Cancer Research , vol.62 , Issue.24 , pp. 7350-7356
    • Ang, K.K.1    Berkey, B.A.2    Tu, X.3    Zhang, H.-Z.4    Katz, R.5    Hammond, E.H.6    Fu, K.K.7    Milas, L.8
  • 5
    • 17844393104 scopus 로고    scopus 로고
    • The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells
    • Al-Hazzaa A, Bowen ID, Randerson P, et al. The effect of ZD1839 (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC-15 cells. Cell Prolif 2005;38:77-86.
    • (2005) Cell Prolif , vol.38 , pp. 77-86
    • Al-Hazzaa, A.1    Bowen, I.D.2    Randerson, P.3
  • 6
    • 0036681995 scopus 로고    scopus 로고
    • Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa)
    • Huang SM, Li J, Armstrong EA, et al. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 2002;62:4300-6. (Pubitemid 34827286)
    • (2002) Cancer Research , vol.62 , Issue.15 , pp. 4300-4306
    • Huang, S.-M.1    Li, J.2    Armstrong, E.A.3    Harari, P.M.4
  • 7
    • 0037674062 scopus 로고    scopus 로고
    • Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
    • Cohen EE, Rosen F, Stadler WM, et al. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol 2003;21:1980-7.
    • (2003) J Clin Oncol , vol.21 , pp. 1980-1987
    • Cohen, E.E.1    Rosen, F.2    Stadler, W.M.3
  • 8
    • 28544432807 scopus 로고    scopus 로고
    • Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
    • Cohen EE, Kane MA, List MA, et al. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2005;11:8418-24.
    • (2005) Clin Cancer Res , vol.11 , pp. 8418-8424
    • Cohen, E.E.1    Kane, M.A.2    List, M.A.3
  • 9
    • 64649097892 scopus 로고    scopus 로고
    • Phase III study of gefitinib 250 compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck
    • Stewart JS, Cohen EE, Licitra L, et al. Phase III study of gefitinib 250 compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1864-71.
    • (2009) J Clin Oncol , vol.27 , pp. 1864-1871
    • Stewart, J.S.1    Cohen, E.E.2    Licitra, L.3
  • 10
    • 0034681783 scopus 로고    scopus 로고
    • Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
    • MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer
    • Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55.
    • (2000) Lancet , vol.355 , pp. 949-955
    • Pignon, J.P.1    Bourhis, J.2    Domenge, C.3
  • 11
    • 0030457015 scopus 로고    scopus 로고
    • Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial
    • Bachaud JM, Cohen-Jonathan E, Alzieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004.
    • (1996) Int J Radiat Oncol Biol Phys , vol.36 , pp. 999-1004
    • Bachaud, J.M.1    Cohen-Jonathan, E.2    Alzieu, C.3
  • 13
    • 0036139727 scopus 로고    scopus 로고
    • Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: Histopathologic and molecular consequences of receptor inhibition
    • Albanell J, Rojo F, Averbuch S, et al. Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 2002;21:110-24.
    • (2002) J Clin Oncol , vol.21 , pp. 110-124
    • Albanell, J.1    Rojo, F.2    Averbuch, S.3
  • 14
    • 1842579584 scopus 로고    scopus 로고
    • Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib
    • Bono P, Krause A, von Mehren M, et al. Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib. Blood 2004;103:2929-35.
    • (2004) Blood , vol.103 , pp. 2929-2935
    • Bono, P.1    Krause, A.2    Von Mehren, M.3
  • 15
    • 63149103474 scopus 로고    scopus 로고
    • Surrogate endpoints in head and neck cancer
    • Chen L, Cohen EE. Surrogate endpoints in head and neck cancer. Lancet Oncol 2009;10:309-10.
    • (2009) Lancet Oncol , vol.10 , pp. 309-310
    • Chen, L.1    Cohen, E.E.2
  • 16
    • 62349097073 scopus 로고    scopus 로고
    • Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: A phase I/II study
    • Cohen EE, Davis DW, Karrison TG, et al. Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study. Lancet Oncol 2009;10:247-57.
    • (2009) Lancet Oncol , vol.10 , pp. 247-257
    • Cohen, E.E.1    Davis, D.W.2    Karrison, T.G.3
  • 17
    • 29144446003 scopus 로고    scopus 로고
    • Epidermal growth factor receptor directed therapy in head and neck cancer
    • Choong NW, Cohen EE. Epidermal growth factor receptor directed therapy in head and neck cancer. Crit Rev Oncol Hematol 2006;57:25-43.
    • (2006) Crit Rev Oncol Hematol , vol.57 , pp. 25-43
    • Choong, N.W.1    Cohen, E.E.2
  • 18
    • 63449130280 scopus 로고    scopus 로고
    • Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications
    • Klussmann JP, Mooren JJ, Lehnen M, et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 2009;15:1779-86.
    • (2009) Clin Cancer Res , vol.15 , pp. 1779-1786
    • Klussmann, J.P.1    Mooren, J.J.2    Lehnen, M.3
  • 19
    • 0032719534 scopus 로고    scopus 로고
    • Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas
    • Akimoto T, Hunter NR, Buchmiller L, et al. Inverse relationship between epidermal growth factor receptor expression and radio-curability of murine carcinomas. Clin Cancer Res 1999;5:2884-90. (Pubitemid 29493967)
    • (1999) Clinical Cancer Research , vol.5 , Issue.10 , pp. 2884-2890
    • Akimoto, T.1    Hunter, N.R.2    Buchmiller, L.3    Mason, K.4    Ang, K.K.5    Milas, L.6
  • 20
    • 0000091450 scopus 로고    scopus 로고
    • The effect of ionizing radiation on signal transduction: Antibodies to EGF receptor sensitize A431 cells to radiation
    • Balaban N, Moni J, Shannon M, et al. The effect of ionizing radiation on signal transduction: antibodies to EGF receptor sensitize A431 cells to radiation. Biochim Biophys Acta 1996; 1314:147-56.
    • (1996) Biochim Biophys Acta , vol.1314 , pp. 147-156
    • Balaban, N.1    Moni, J.2    Shannon, M.3
  • 21
    • 0030772168 scopus 로고    scopus 로고
    • Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
    • Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997;15:1191-7.
    • (1997) Oncogene , vol.15 , pp. 1191-1197
    • Schmidt-Ullrich, R.K.1    Mikkelsen, R.B.2    Dent, P.3
  • 22
    • 32144433159 scopus 로고    scopus 로고
    • Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    • Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78.
    • (2006) N Engl J Med , vol.354 , pp. 567-578
    • Bonner, J.A.1    Harari, P.M.2    Giralt, J.3
  • 23
    • 4644345181 scopus 로고    scopus 로고
    • Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy
    • Chua DT, Nicholls JM, Sham JS, et al. Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2004;59:11-20.
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 11-20
    • Chua, D.T.1    Nicholls, J.M.2    Sham, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.